A detailed history of Family Firm, Inc. transactions in Mckesson Corp stock. As of the latest transaction made, Family Firm, Inc. holds 1,139 shares of MCK stock, worth $666,121. This represents 0.15% of its overall portfolio holdings.

Number of Shares
1,139
Previous 1,138 0.09%
Holding current value
$666,121
Previous $526,000 16.16%
% of portfolio
0.15%
Previous 0.13%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$473.42 - $539.26 $473 - $539
1 Added 0.09%
1,139 $611,000
Q4 2023

Feb 05, 2024

SELL
$437.42 - $470.64 $8,310 - $8,942
-19 Reduced 1.64%
1,138 $526,000
Q3 2023

Oct 19, 2023

SELL
$402.4 - $446.42 $402 - $446
-1 Reduced 0.09%
1,157 $503,000
Q2 2023

Aug 08, 2023

BUY
$354.01 - $427.31 $354 - $427
1 Added 0.09%
1,158 $494,000
Q1 2023

May 01, 2023

BUY
$335.35 - $386.06 $335 - $386
1 Added 0.09%
1,157 $411,000
Q4 2022

Feb 07, 2023

SELL
$346.68 - $397.58 $1,040 - $1,192
-3 Reduced 0.26%
1,156 $433,000
Q3 2022

Nov 15, 2022

BUY
$321.25 - $373.84 $1,285 - $1,495
4 Added 0.35%
1,159 $394,000
Q2 2022

Dec 01, 2022

SELL
$300.57 - $336.42 $300 - $336
-1 Reduced 0.09%
1,158 $378,000
Q1 2022

Nov 30, 2022

SELL
$244.61 - $310.48 $733 - $931
-3 Reduced 0.26%
1,156 $354,000
Q4 2021

Feb 02, 2022

SELL
$198.21 - $248.9 $9,117 - $11,449
-46 Reduced 3.83%
1,155 $287,000
Q3 2021

Oct 22, 2021

BUY
$188.42 - $208.66 $753 - $834
4 Added 0.33%
1,201 $247,000
Q2 2021

Jul 21, 2021

SELL
$184.89 - $202.68 $16,824 - $18,443
-91 Reduced 7.07%
1,197 $229,000
Q4 2020

Jan 20, 2021

BUY
$143.79 - $183.66 $185,201 - $236,554
1,288 New
1,288 $238,000
Q1 2018

Apr 26, 2018

SELL
$138.75 - $176.72 $266,677 - $339,655
-1,922 Closed
0 $0
Q2 2017

Aug 08, 2017

BUY
N/A
1,922
1,922 $316,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $84.1B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Family Firm, Inc. Portfolio

Follow Family Firm, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Family Firm, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Family Firm, Inc. with notifications on news.